Altesa BioSciences, Inc., Launches Operations to Develop, Commercialize Drugs for Respiratory Viruses and Global Viral Threats Feb 10, 2022 https://altesabio.com/wp-content/uploads/2022/02/NR_ALTESA_LAUNCHES_OPS_02.10.2022.pdf
Recent Comments